Oxford Nanopore Technologies plc (USD) Oxford Nanopore Technologies plc is dedicated to the development and commercialization of an innovative technology platform. This platform leverages nanopore-based sensing to facilitate the analysis of various types of molecules. The company's product line includes several key devices: The MinION, a portable unit designed for sequencing deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). The GridION, a self-contained benchtop instrument capable of operating and analyzing up to five MinION or Flongle flow cells. The MinION Mk1C, which integrates basecalling and data analysis, featuring a touchscreen interface and wireless connectivity. Flongle, an adapter that allows the use of Flongle flow cells with MinION or GridION devices. The GridION Mk1, another benchtop nanopore sequencer offered by the company. The PromethION 2 Solo and PromethION 2, providing an economical gateway to high-yield PromethION sequencing. Larger-scale needs are addressed by the PromethION 24 and PromethION 48 benchtop nanopore sequencers, which cater to multiple users for multi-sample and multi-experiment sequencing. VolTRAX, a USB-powered device that automates laboratory preparation steps prior to nanopore sequencing. In addition to hardware, Oxford Nanopore offers a suite of software solutions: MinKNOW, a software application for data acquisition, real-time analysis with feedback, local basecalling, and data streaming. Specialized Basecalling tools for identifying the sequence and type of bases in DNA/RNA molecules. EPI2ME, a cloud-based platform for comprehensive, real-time analysis of nanopore data. EPI2ME Labs, a bioinformatics resource designed to help users enhance their expertise and confidence in analyzing nanopore-based sequencing data. The company is also actively developing new products, including the MinION Mk1D, Ubi, Plongle, and SmidgION. Its products are available for purchase online. Established in 2005, the company was initially known as Oxford NanoLabs Limited before changing its name to Oxford Nanopore Technologies Limited in May 2008. Oxford Nanopore Technologies plc maintains its headquarters in Oxford, United Kingdom.

Oxford Nanopore Technologies plc (USD) Active

Gosling Building, Oxford, GB, OX4 4DQ

Stock Price USD

Price Change

Last Dividend USD

ONTTF's stock peer is BRCTF (BioArctic AB (publ))

ONTTF's stock peer is CSPHF (CStone Pharmaceuticals)

ONTTF's stock peer is MEOBF (Mesoblast Limited)

ONTTF's stock peer is NURPF (Neuren Pharmaceuticals Limited)

ONTTF's stock peer is PHMMF (Pharma Mar, S.A.)

ONTTF's stock peer is PPTDF (PeptiDream Inc.)

ONTTF's stock peer is STSEY (Stratec SE)

ONTTF's stock peer is SZUKF (Suzuken Co., Ltd.)

ONTTF's stock peer is ZRSEF (DocMorris AG)

Healthcare Biotechnology

Oxford Nanopore Technologies plc is dedicated to the development and commercialization of an innovative technology platform. This platform leverages nanopore-based sensing to facilitate the analysis of various types of molecules. The company's product line includes several key devices: The MinION, a portable unit designed for sequencing deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). The GridION, a self-contained benchtop instrument capable of operating and analyzing up to five MinION or Flongle flow cells. The MinION Mk1C, which integrates basecalling and data analysis, featuring a touchscreen interface and wireless connectivity. Flongle, an adapter that allows the use of Flongle flow cells with MinION or GridION devices. The GridION Mk1, another benchtop nanopore sequencer offered by the company. The PromethION 2 Solo and PromethION 2, providing an economical gateway to high-yield PromethION sequencing. Larger-scale needs are addressed by the PromethION 24 and PromethION 48 benchtop nanopore sequencers, which cater to multiple users for multi-sample and multi-experiment sequencing. VolTRAX, a USB-powered device that automates laboratory preparation steps prior to nanopore sequencing. In addition to hardware, Oxford Nanopore offers a suite of software solutions: MinKNOW, a software application for data acquisition, real-time analysis with feedback, local basecalling, and data streaming. Specialized Basecalling tools for identifying the sequence and type of bases in DNA/RNA molecules. EPI2ME, a cloud-based platform for comprehensive, real-time analysis of nanopore data. EPI2ME Labs, a bioinformatics resource designed to help users enhance their expertise and confidence in analyzing nanopore-based sequencing data. The company is also actively developing new products, including the MinION Mk1D, Ubi, Plongle, and SmidgION. Its products are available for purchase online. Established in 2005, the company was initially known as Oxford NanoLabs Limited before changing its name to Oxford Nanopore Technologies Limited in May 2008. Oxford Nanopore Technologies plc maintains its headquarters in Oxford, United Kingdom.

Income Statement

Dividend Stats Yield is calculated via trailing-12-month period

Ex-Dividend	Payment Date	Dividend	Yield	Dividend Frequency
Dividend Data Not Exist

Disclaimers

StockQuay.com is not operated by a broker, dealer, or registered investment advisor. Under no circumstances should any information published on StockQuay.com be considered a recommendation to buy, sell, or hold any security. The content on this site and in its associated newsletters is intended solely for informational and educational purposes and does not constitute investment advice or financial recommendations.

Individuals or entities featured or referenced on StockQuay.com may engage in trading activity involving the securities mentioned in any article or report before or after such content is published. These individuals or entities are not affiliated with StockQuay.com, and their inclusion does not imply endorsement or accuracy of their views or actions.

StockQuay.com, its owners, or its affiliates shall not be held liable to any user or third party for any damages or losses arising from the use of content on this website. This includes, but is not limited to, investment losses, loss of profit, loss of data, missed opportunities, or indirect, incidental, or consequential damages.

Data is updated daily and is not guaranteed to be accurate or complete.

Past performance is not indicative of future results. Please conduct your own research or consult with a qualified financial advisor before making any investment decisions